Dr Reddy'S Laboratories On Thursday Said It Has Launched In The Us Generic Bupropion Hydrochloride Extended-Release Tablets Indicated As An Aid To Smoking Cessation Treatment.The Company Has Launched Bupropion Hydrochloride Extended-Release Tablets Usp (Sr), Approved By The United States Food And Drug Administration (Usfda), The Drug Firm Said In A Filing To Bse.The Product Is A Generic Version Of Gsk Group Of Companies' Zyban Extended-Release Tablets, It Added.According To Iqvia Health, The Zyban Brand And Generic Had Us Sales Of Around Usd 5.4 Million Mat For The 12 Months Ended June 2019, The Company Said.Dr Reddy'S Tablets Are Available As 150 Mg Dosage Strength In Bottle Count Sizes Of 60, It Added.Shares Of Dr Reddy'S Laboratories Were Trading At Rs 2,667.05 Per Scrip On Bse, Up 2.51 Per Cent From The Previous Close.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!